Patents Assigned to Kanoldt Arzneimittel GmbH
  • Use of stigmasta-4-en-3-one in the treatment of androgen dependent diseases
    Patent number: 5264428
    Abstract: A pharmaceutical preparation which comprises stigmasta-4-en-3-one as the active ingredient. This active ingredient can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.
    Type: Grant
    Filed: April 29, 1992
    Date of Patent: November 23, 1993
    Assignee: Kanoldt Arzneimittel GmbH
    Inventor: August S. Streber
  • Hydroxyoctadecadienic acid for the treatment of estrogen-dependent disease
    Patent number: 5102912
    Abstract: This invention describes the use of a hydroxyoctadecadienic acid, its acid oxidized to keto form or the ester derivatives of the acids, where the ester derivatives are low esters with 1 to 4 carbon atoms for the preparation of a pharmaceutical for treatment of breast carcinomas or benign prostatic hyperplasia. In particular, those compounds are suitable in which the double bonds and the hydroxy group or the oxo group are present on the carbon atoms at positions 9 to 13.
    Type: Grant
    Filed: April 18, 1991
    Date of Patent: April 7, 1992
    Assignee: Kanoldt Arzneimittel GmbH
    Inventor: August S. Streber
  • Pharmaceutical composition of ester derivatves of hecogenin and a method of use in the treatment of benign prostata hyperplasia
    Patent number: 5002939
    Abstract: The invention concerns a pharmaceutical composition which comprises lower alkyl ester derivatives of hecogenin and pharmaceutically compatible carriers. The pharmaceutical composition has an inhibiting effect on cell growth and can be used for the causal treatment of benign prostata hyperplasia in human beings and in animals.
    Type: Grant
    Filed: November 13, 1989
    Date of Patent: March 26, 1991
    Assignee: Kanoldt Arzneimittel GmbH
    Inventor: August S. Streber